CORRESP 1 filename1.htm

 

 

 

November 30, 2020

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

 

  RE: Medigus Ltd. (CIK  0001618500)
    Registration Statement No. 333-249797 on Form F-1 (the “Registration Statement”)

 

Ladies and Gentlemen:

 

Medigus Ltd. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective on December 1, 2020 at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable.

 

The Registrant understands that the Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act as they relate to the proposed public offering of the securities specified in the Registration Statement.

 

 

  Very truly yours,
   
  MEDIGUS LTD.
   
  By:  /s/ Tatiana Yosef
    Tatiana Yosef
    Chief Financial Officer